May 3-6 Rotterdam, Netherlands
![]() |
![]() |
![]() |
![]() |
LBVeP-1 | Technical refinements of RAPID technique: continuing innovation in a cutting-edge procedure | Umberto Cillo | ![]() |
![]() |
|||
FvP-1 | Training the Next Generation of Transplant Surgeons with 3D hands-on liver models | Jorge Sanchez-Garcia | ![]() |
![]() |
|||
VeP-1 | Robotic right hepatectomy and portal vein resection for HCC with portal vein tumor thrombosis | Paolo Magistri | ![]() |
![]() |
|||
eP-001 | Robotic versus open liver resection for HCC | Paolo Magistri | ![]() |
![]() |
|||
FP-001 | Estimating the Lifespan Following Paediatric Liver Transplantation: Is a Near-Normal Life Expectancy Attainable and What Factors Influence It? | Nicholas Syn | ![]() |
![]() |
|||
VeP-2 | Gallbladder saving operation in laparoscopic living donor extended left hemihepatectomy | Kyung-Suk Suh | ![]() |
![]() |
|||
FvP-2 | Liver Transplantation Using the Aborted Liver Graft with Re-do Pure Laparoscopic Living Donor Right Hemihepatectomy | YoungRok Choi | ![]() |
![]() |
|||
FP-002 | Redefining the concept of clinically significant graft steatosis in the era of automated assessment | Damiano Patrono | ![]() |
![]() |
|||
LBVeP-2 | Mixed-reality guided size-matching and graft reduction in paediatric living donor liver transplantation | Zong Jie Koh | ![]() |
![]() |
|||
eP-003 | Surgical reconstructions of hepatic artery variations for ex-situ normothermic dynamic preservation in liver transplantation | Gabriela Chullo | ![]() |
![]() |
|||
VeP-3 | Liver Transplantation as a Bridge for Portal Hypertension Management in Cirrhotic Patient Due to Bucrylate-Treated Variceal Infection | Christian Robles | ![]() |
![]() |
|||
LBVeP-3 | The use of blower- mister blower device to facilitate biliary anastamosis in living donor liver transplantation | Abhishek Yadav | ![]() |
![]() |
|||
FP-003 | Development of a Liver Atlas using over 1,000 consecutive deceased donor livers to identify hepatic steatosis prior to retrieval | Syed Hussain Abbas | ![]() |
![]() |
|||
FvP-3 | Surgical technique for Living donor Liver Transplantation with Inferior Vena Cava Replacement | Sunhawit Junrungsee | ![]() |
![]() |
|||
LBeP-003 | Risk Alleles of PNPLA3, TM6SF2, and HSD17B13 of Donors are Closely Related to Graft Steatosis and Steatohepatitis After Liver Transplantation | Kenta Makino | ![]() |
![]() |
|||
FP-004 | A systematic review and network meta-analyses on the effects of intraoperative vasopressors on postoperative outcomes in liver transplantation | François Martin Carrier | ![]() |
![]() |
|||
eP-004 | Liver transplantation in patients with secondary biliary cirrhosis in a Single Center | Mario Viltoba | ![]() |
![]() |
|||
FvP-4 | PARENCHYMAL TRANSECTION WITH HARMONIC SCALPEL IN TOTAL ROBOTIC DONOR HEPATECTOMY | FYSAL KOLLANTA VALAPPIL | ![]() |
![]() |
|||
LBVeP-4 | Complete IVC clearance before parenchymal transection in laparoscopic donor hepatectomy | VISHAL KUMAR CHORASIYA | ![]() |
![]() |
|||
LBeP-004 | M-RNA GENE EXPRESSION BY REAL-TIME REVERSE TRANSCRIPTION PCR ON LIVER BIOPSIES OF PATIENTS ENROLLED IN THE SIMVALT TRIAL: RANDOMIZED DOUBLE-BLIND CLINICAL STUDY | Duilio Pagano | ![]() |
![]() |
|||
FP-005 | Fabrication of human hepatic decellularized extracellular matrix derived liver scaffold A novel insight into an alternative therapy for Liver degeneration | Catherine Ann Martin | ![]() |
![]() |
|||
VeP-5 | Difficult Porta Dissection in Laparoscopic Donor Hepatectomy | VISHAL CHORASIYA | ![]() |
![]() |
|||
LBVeP-5 | Full-left/full-right liver splitting with middle hepatic vein and caval partition during dual hypothermic oxygenated machine perfusion | Alessandro Furlanetto | ![]() |
![]() |
|||
FvP-5 | Various retracting techniques for the laparoscopic living donor hepatectomy - double rubber extraction to facilitate liver resection | Kwang Hyun Kim | ![]() |
![]() |
|||
FP-006 | The effect of donor dominant one-way HLA mismatch on liver transplantation outcomes: An analysis of Korean Organ Transplantation Registry (KOTRY) database | Sunghae Park | ![]() |
![]() |
|||
FvP-6 | Back-Table Portal Vein and Hepatic Vein Reconstruction by Using Autologous Falciform Ligament: Video Case Sharing | Yu Cheng Lin | ![]() |
![]() |
|||
FvP-7 | 3D pre-operative imaging assisted transition of liver transection from CUSA to Harmonic scalpel in total robotic donor hepatectomy | Kamal Yadav | ![]() |
![]() |
|||
FP-007 | Genetic modification of Rat Liver Using Lentiviral Vectors During Ex Vivo Machine Perfusion | Irina CLJ Filz von Reiterdank | ![]() |
![]() |
|||
eP-008 | Evolution of surgical strategies in the setting of Liver Transplant (LT) for Polycystic Liver and Kidney Disease (PLKD) | Gabriela Chullo | ![]() |
![]() |
|||
FP-008 | Interplay Between Intrahepatic Macrophages and Alloreactive and Regulatory T-cells mediates the Complex Alloimmune Microenvironment During Acute Rejection in Clinical Liver Transplantation | Juliet Emamaullee | ![]() |
![]() |
|||
FvP-8 | Portal vein reconstruction in pediatric liver transplantation using end-to-side jump graft | Jae-Yoon Kim | ![]() |
![]() |
|||
LBeP-009 | Is It The Proper Time To Re define Small For Size Syndrome After Living Donor Liver Transplant; Opening The Pandora Box | Ahmed Zidan | ![]() |
![]() |
|||
eP-009 | A single center Brazilian experience of hepatic Resection After liver transplantation: results and analysis | Ronaldo Andrade | ![]() |
![]() |
|||
eP-010 | Upfront portal vein arterialization for complex portal vein thrombosis: a new technique that reestablish splanich system | Camila Girao | ![]() |
![]() |
|||
FP-010 | Carbapenemase gene detection assays Do they improve outcomes in liver transplant recipients colonised with Carbepenem resistant Enterobacteriaceae ? | Amal Francis Sam | ![]() |
![]() |
|||
FP-011 | Liver Transplantation Restores A Circulating Environment That Supports Healthy Platelet Aggregation Within Two Hours Of Reperfusion | Mignote Yilma | ![]() |
![]() |
|||
eP-011 | Novel surgical modification in piggyback technique in orthotopic liver transplantation | Dr Paramesha KN | ![]() |
![]() |
|||
FP-012 | Effect of Coping Skill Enhancement Therapy on Short Term Outcomes after Living Donor Liver Transplantation: A Randomized Controlled Trial | Dhananjay Saxena | ![]() |
![]() |
|||
eP-012 | Fibrinogen and albumin synthesis rates in upper abdominal surgery with and without major hepatectomy | Gabriel Dumitrescu | ![]() |
![]() |
|||
LBeP-013 | Absorbable Self-Expandable Biliary Stent as a Preventive Treatment of Biliary Complications in Liver Transplant | Pedro Antonio Lopez-Lopez | ![]() |
![]() |
|||
LBeP-014 | Ischemia-free liver transplantation in the rat | MASATO FUJIYOSHI | ![]() |
![]() |
|||
FP-014 | Evaluation of Liver Maximum Capacity (LiMAx) Measurements to Monitor Hepatocellular Function during Extended Normothermic Machine Perfusion | George Clarke | ![]() |
![]() |
|||
eP-014 | A review of blood utilization in a large liver transplant center after implementation of simple measures | Khoa Tran | ![]() |
![]() |
|||
FP-015 | Impact of the High Baseline Anti-A/B Antibody titer on the clinical outcomes in ABO-incompatible Living Donor Liver Transplantation | Hae Won Lee | ![]() |
![]() |
|||
eP-015 | Applicability and prognostic value of liver frailty index in liver transplant recipients from an Indian centre | Amal Francis Sam | ![]() |
![]() |
|||
LBeP-015 | Early drain removal after live liver donor hepatectomy is safe - A randomized control trial | Parthiban Durairaj | ![]() |
![]() |
|||
LBeP-016 | Risk factors and managements of intra-operative portal vein thrombosis in living-donor liver transplantation due to biliary atresia: a single center experience from China mainland | Kai Wang | ![]() |
![]() |
|||
FP-016 | Early prediction of bacterial infection risk after liver transplantation for cirrhosis: the PRELINFO score | Emmanuel Weiss | ![]() |
![]() |
|||
eP-016 | Futility criteria of re-transplantation for Early Non-Function after liver transplantation: a retrospective multicenter study | Clara Timsit | ![]() |
![]() |
|||
eP-017 | Impact of cumulative fluid balance on post-operative outcomes in living donor liver transplantation | Amal Francis Sam | ![]() |
![]() |
|||
FP-017 | Diagnostic value and assessment of treatment efficacy of 18F-FDG PET/CT in pediatric patients with posttransplant lymphoproliferative disorder after liver transplantation | Jing-Yi Liu | ![]() |
![]() |
|||
LBeP-017 | Intentionally genome altered porcine livers perfused with human blood products can be sustained 72 hours ex vivo | Eliezer Katz | ![]() |
![]() |
|||
FP-018 | Improved Outcomes of Extended Criteria Donors in Liver Transplantation for Hepatocellular Carcinoma: A National Cohort Analysis | Elizabeth Brombosz | ![]() |
![]() |
|||
eP-18 | A Bimodal Distribution of Blood Loss and Blood Product Administration in Patients Undergoing Orthotopic Liver Transplantation | Nicholas Rothbard | ![]() |
![]() |
|||
FP-019 | The potential to develop a completely robotic living donor liver transplant surgery A systematic approach | Ramkiran Cherukuru | ![]() |
![]() |
|||
LBeP-019 | No association between arterial reperfusion parameters and clinical outcomes for liver transplantation using donation after circulatory death grafts | Alessandro Parente | ![]() |
![]() |
|||
FP-020 | Markers of Cirrhotic Cardiomyopathy May Not Improve Following Liver Transplantation | Manhal Izzy | ![]() |
![]() |
|||
eP-020 | Intraoperative Heparinization During Orthotopic Liver Transplantation | Christopher Wray | ![]() |
![]() |
|||
FP-021 | Impact of Preformed Donor-Specific Antibody Compared to that of ABO Incompatibility in Living Donor Liver Transplantation Using Propensity Score Matched Analysis | Jiyoung Kim | ![]() |
![]() |
|||
eP-021 | Implementation of an early extubation pathway in low-risk liver transplant recipients reduces duration of invasive mechanical ventilation and hospital resources- a quality improvement project | Stephanie Chartier-Plante | ![]() |
![]() |
|||
FP-022 | Identification of novel liver transplant biopsies phenotypes associated with distinct biological profiles and allograft survival | Zeynep Demir | ![]() |
![]() |
|||
eP-022 | Early extubation after liver transplantation has a low rate of emergent reintubation | Alessandro Galli | ![]() |
![]() |
|||
LBeP-022 | CXCR3 Hepatic Natural Killer Cells Promote Hepatic Ischemia-reperfusion Injury in Liver Transplantation | Xinxiang Yang | ![]() |
![]() |
|||
FP-023 | Potential of Mitochondrial Dysfunction Biomarkers during Ex-vivo Normothermic liver perfusion | Khaled Ali | ![]() |
![]() |
|||
eP-023 | Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish Cohort | Isabel Conde | ![]() |
![]() |
|||
FP-024 | LIVER PAIRED EXCHANGE TRANSPLANTATION: OVERCOMING THE OBSTACLES IN LIVING DONOR LIVER TRANSPLANTATION | TEVF&304;K TOLGA &350;AH&304;N | ![]() |
![]() |
|||
eP-024 | Risk factors for prolonged mechanical ventilation after liver transplantation | Marta Caballero | ![]() |
![]() |
|||
FP-025 | CALCINEURIN-INHIBITOR DISCONTINUATION CAN REDUCE THE RISK OF DE NOVO MALIGNANCIES AFTER LIVER TRANSPLANTATION FOR ALCOHOL-RELATED LIVER DISEASE | Domitille Erard | ![]() |
![]() |
|||
eP-025 | Pretransplant coronary revascularization and patient outcome - comparing Bare Metal with Drug Eluting Stents | Vijay Vohra | ![]() |
![]() |
|||
eP-026 | PREDICTORS OF INTRAOPERATIVE TRANSFUSION REQUIREMENT IN ADULT LIVER TRANSPLANT RECIPIENTS | Amal Francis Sam | ![]() |
![]() |
|||
LBeP-026 | An Experimental Rodent Model for Long-Term Ex-Vivo Normothermic Machine Perfusion of Livers | Mark Ly | ![]() |
![]() |
|||
FP-026 | Hepatic Congestion-Linked Intrahepatic Biliary Stricture In The Right Liver Grafts | Hyun Hwa Choi | ![]() |
![]() |
|||
LBeP-027 | Insulin Secretion in Liver Transplant Recipients Following Conversion to a Prolonged Release Tacrolimus Formulation | Gerald Minuk | ![]() |
![]() |
|||
FP-027 | High Expression of SNGH16 is A Candidate Predictive Marker of Regional Therapy Resistance in Hepatocellular Carcinoma | Fuat Aksoy | ![]() |
![]() |
|||
eP-028 | Mean Systemic Filling Pressure (MSFP) trends in liver transplant recipients- a pilot study | Karthik Thirumurugan | ![]() |
![]() |
|||
LBeP-028 | Postoperative negative-pressure incision therapy after liver transplant (PONILITRANS study): A randomized controlled trial | Victor Lopez-Lopez | ![]() |
![]() |
|||
FP-028 | NON-INVASIVE DETECTION OF HYPER-METHYLATED CPG ISLANDS IN CELL-FREE DNA: A BLOOD-BASED EPIGENETIC MARKER TOOL FOR SURVEILLANCE OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS AN INTERIM ANALYSIS | Vasanthakumar Gunasekaran | ![]() |
![]() |
|||
eP-029 | Fast-track extubation after liver transplantation a centres evolution in practice | Arun Menon | ![]() |
![]() |
|||
FP-029 | Outcomes of living donor liver transplantation in acute on chronic liver failure Experience from a single center in India | Abhijith Uthaman | ![]() |
![]() |
|||
eP-030 | The impact of splenic artery ligation on patient outcomes and thrombocytopenia following living donor liver transplantation | Susan Paulin | ![]() |
![]() |
|||
LBeP-030 | Optimizing 45 Minute DCD Liver Grafts Using Stabilized Plasmin in a Static Cold Storage Orthotopic Rat Liver Transplant Model | Riley Kahan | ![]() |
![]() |
|||
FP-030 | Utility of novel glucagon-like peptide-1 receptor agonists as anti-obesity medications in liver transplant recipients | Seth Richardson | ![]() |
![]() |
|||
FP-031 | Dual hypothermic oxygenated machine perfusion (DHOPE) is associated with improved recovery of acute kidney injury (AKI) after donation after circulatory death liver transplantation | Femke de Goeij | ![]() |
![]() |
|||
eP-031 | Etiologies and outcome of acute liver failure listed for liver transplantation in Switzerland | Ansgar Deibel | ![]() |
![]() |
|||
LBeP-031 | CELIAC TRUNK STENOSIS BY MEDIAN ARCUATE LIGAMENT IN ORTHOTOPIC LIVER TRANSPLANTATION: ANALYSIS OF BILIARY COMPLICATIONS | Flavia Feier | ![]() |
![]() |
|||
FP-032 | Normothermic Machine Perfusion of the Liver: Early Outcomes and Hospital Resource Utilization in a High-Volume U.S. DCD Liver Transplant Center | Chi Zhang | ![]() |
![]() |
|||
eP-032 | IMPACT OF DONOR AGE ON OUTCOMES OF LIVING DONOR LIVER TRANSPLANT RECIPIENTS | Susan Paulin | ![]() |
![]() |
|||
FP-033 | Improved outcomes of kidney after liver transplantation after the implementation of the safety net policy | Hani Wadei | ![]() |
![]() |
|||
eP-33 | Interim results of a mixed-methods Study Within A Trial (SWAT) to understand recruitment to a feasibility trial of octreotide infusion during liver transplantation | Edgar Brodkin | ![]() |
![]() |
|||
LBeP-033 | A Comparative evaluation of Thromboelastography versus Thromboelastometry for coagulopathy correction in patients of liver cirrhosis with non-variceal bleed Prospective observational study | Nimi Gopal | ![]() |
![]() |
|||
FP-34 | Immune response to COVID-19 vaccination in Liver transplant recipients | Dinesh Jothimani | ![]() |
![]() |
|||
eP-034 | Role of N-terminal pro-brain natriuretic peptide in predicting adverse outcomes in living donor liver transplant recipients | Susan Paulin | ![]() |
![]() |
|||
eP-036 | Challenging Case of Pediatric Liver transplant with Alagilles Syndrome with Moderate Pulmonary Stenosis | Ashish Malik | ![]() |
![]() |
|||
FP-036 | Pre-Transplant Donor Specific Antibodies Are Not Associated with Impaired Renal Function Post-Transplant in Simultaneous Liver-Kidney Transplant Recipients | Mozhgon Moaddab | ![]() |
![]() |
|||
LBeP-037 | Re-evaluating the 6 month rule prior to liver transplant: A clinical practice guideline | Joanna Dionne | ![]() |
![]() |
|||
eP-037 | Use of Whole Blood Transfusion During Liver Transplantation: A Retrospective Review | Samir Gandhi | ![]() |
![]() |
|||
FP-37 | Normothermic Mechanical Perfusion (NMP) significantly reduces the risk of ischemic cholangiopathy in recipients of donation after cardiac death (DCD) Liver Transplants | Bashar Aqel | ![]() |
![]() |
|||
FP-038 | A Contemporary Analysis of 20,153 Deceased Donor Liver Biopsies | Madhukar Patel | ![]() |
![]() |
|||
LBeP-038 | TRANSIENT ELASTOGRAPHY Vs ULTRASOUND TO DETERMINE LIVER VIABILITY FOR DONATION AND TRANSPLANTATION | Ernesto Duarte Tagles | ![]() |
![]() |
|||
eP-039 | Impact of preoperative hyponatremia on postoperative recovery outcomes following liver transplantation | Susan Paulin | ![]() |
![]() |
|||
FP-039 | Six Hundred Eighteen Consecutive Pediatric Liver Transplant: The King Faisal Hospital & Research Center Experience | Ahmed Zidan | ![]() |
![]() |
|||
FP-040 | Post Liver-Transplant Survival for Mixed Hepatocellular Carcinoma-Cholangiocarcinoma and Propensity-Matched Hepatocellular Carcinoma Patients | Sudha Kodali | ![]() |
![]() |
|||
eP-040 | Similar rates of liver transplantation (LT) for acute liver failure (ALF) but changes in patient profiles in a Spanish multicentre cohort | Isabel Conde | ![]() |
![]() |
|||
eP-041 | Native whole blood (TRUE-NATEM) and recalcified citrated blood (NATEM) reference value validation with ROTEM delta | Uzung Yoon | ![]() |
![]() |
|||
LBeP-041 | Feasibility of enhance recovery after surgery in liver transplantation | Komal Ray | ![]() |
![]() |
|||
eP-042 | Liver transplantation in Amanita phalloides and acetaminophen induced acute liver failure | Emilia Kruk | ![]() |
![]() |
|||
eP-043 | The SATA multicenter Liver Transplant Outcomes in Anesthesia Database (Liver-TOAD): building the foundation for research collaboration in transplant anesthesia | Dieter Adelmann | ![]() |
![]() |
|||
LBeP-043 | The effect of Short term weight loss intervention with modified GM diet in liver donors on hepatic steatosis in living donor liver transplantation | Abhishek Yadav | ![]() |
![]() |
|||
eP-044 | Liver Transplantation during the COVID-19 Pandemic: Considerations and Approach in a Southeast Asian Tertiary Medical Centre | Sook Muay Tay | ![]() |
![]() |
|||
LBeP-044 | LIVING DONOR LIVER TRANSPLANTATION FOR ADULT PATIENTS WITH LOW MELD IN AN AREA WITH LOW RATE OF DECEASED DONATION: EUROPEAN SINGLE CENTER ANALYSIS | Duilio Pagano | ![]() |
![]() |
|||
eP-045 | Effect of Mechanical Ventilation on Postoperative Outcomes of Patients Undergoing Living Donor Liver Transplantation | Yu-Ling Liu | ![]() |
![]() |
|||
eP-46 | Portal flow modulation on trial a feasibility RCT of octreotide in liver transplant | Ilya Kantsedikas | ![]() |
![]() |
|||
eP-050 | Defining Tumor-Associated Macrophage Subpopulation in Intrahepatic Cholangiocarcinoma as Prognostic and Therapeutic Targets | Varvara Kirchner | ![]() |
![]() |
|||
eP-051 | Removal of circulating nucleosomes/neutrophil extracellular traps (NETs) reduces ex-situ reperfusion injury in porcine DCD livers preserved with normothermic machine perfusion (NMP) | Fungai Dengu | ![]() |
![]() |
|||
eP-052 | Histone deacetylase-11 (HDAC11) inhibitors (HDACi) are effective, novel therapy for non-alcoholic steatohapatitis (NASH) | Zhi Zhong | ![]() |
![]() |
|||
LBeP-053 | Changing management of type 1 Abernethy syndrome (congenital porto- caval shunt) | annalisa dolcet | ![]() |
![]() |
|||
eP-053 | The pro-hepato-regenerative effect of MKK4-inhibition in a preclinical porcine model of NASH | Philipp Felgendreff | ![]() |
![]() |
|||
LBeP-054 | Bloodstream infections after liver transplantation: risk factors and outcomes | Chih-Chi Wang | ![]() |
![]() |
|||
eP-056 | Formoterol, a Long-Acting 2-Adrenergic Receptor (2AR) Agonist, Stimulates Mitochondrial Biogenesis (MB) and Improves Liver Regeneration after Major Liver Resection (MLR) | Zhi Zhong | ![]() |
![]() |
|||
LBeP-058 | Psychological sequelae and health-related quality of life after LTx | Anke Hierundar | ![]() |
![]() |
|||
eP-058 | Identification of hepatocyte-restricted antigens, epitopes, and T cell receptors to treat recurrent hepatocellular carcinoma after liver transplantation | Dave Sprengers | ![]() |
![]() |
|||
eP-059 | Defining Metabolic changes of Human liver grafts during Long-term Normothermic Machine Perfusion | Joanna Huang | ![]() |
![]() |
|||
LBeP-059 | Two-stage liver resection with Rex shunt (Tr-Rex Procedure) to Augment Flow and function Prior to Right Hemihepatectomy in an adult with main Portal Vein Occlusion | Bobby VM Dasari | ![]() |
![]() |
|||
eP-060 | A microfluidic bile-duct-on-a-chip platform for studying biliary epithelium in a dish | Jorke Willemse | ![]() |
![]() |
|||
LBeP-061 | Reconstruction of Hepatic Vein by Using Falciform Ligament in Living Donor Liver Transplantation | Teng-Yuan Hou | ![]() |
![]() |
|||
eP-62 | Liver Resident Memory T cells are and Normothermic Liver Perfusion | David Al-Adra | ![]() |
![]() |
|||
LBeP-063 | Basiliximab maintenance for immunosuppression induced Haemolytic UraemicSyndrome - Thrombotic Thrombocytopenic Purpura (HUS-TTP) after Deceased Donor Liver Transplantation | Madhavi Nayak | ![]() |
![]() |
|||
eP-063 | Prediction of the Degree of Hepatic Ischemia-Reperfusion Injury during Normothermic Machine Perfusion Based on the Function of Multidrug Resistance-Associated Protein 2 | Joohyun Kim | ![]() |
![]() |
|||
eP-064 | Single Nucleus Sequencing suggests Decreased Regenerative capacity in Graft Fibrosis post-Liver Transplantation | Mamatha Bhat | ![]() |
![]() |
|||
LBeP-064 | Re-expansion pulmonary edema vs alveolar-pleural fistula during liver transplant: Diagnosis and management | Neal Al-Attar | ![]() |
![]() |
|||
eP-065 | Gene Signature Present within Background Liver Parenchyma of Transplant Recipients with Hepatocellular Carcinoma | Audrey Brown | ![]() |
![]() |
|||
LBeP-065 | Donation after brain death followed by circulatory death (DBCD) and a successful deceased donor liver transplant- The first case reported in Sri Lanka | Senani Samarasinghe | ![]() |
![]() |
|||
eP-066 | In vitro Effects of Neopterin on Invasion, Metastasis and Proliferation of Hepatocellular Cancer Cell Lines | TEVF&304;K TOLGA &350;AH&304;N | ![]() |
![]() |
|||
LBeP-066 | Liver transplantation during COVID-19 pandemic in Poland; numbers, indications and results | Jaroslaw Czerwinski | ![]() |
![]() |
|||
LBeP-067 | Gullian-Barrè Syndrome in a Liver Transplant Recipient | Madhavi Nayak | ![]() |
![]() |
|||
eP-068 | Hypoxia inducible factor modulation during normothermic machine perfusion (NMP) accelerates reduction in hepatic steatosis | Syed Hussain Abbas | ![]() |
![]() |
|||
eP-069 | DNA methylation-induced gene expression changes result in hepatic ischemia-reperfusion injury in deceased donor liver transplant recipients | Haseeb Zubair | ![]() |
![]() |
|||
eP-071 | Single Nucleus Sequencing reveals Hippo signaling as a Key Driver of Human Liver Regeneration | Mamatha Bhat | ![]() |
![]() |
|||
eP-072 | Mitochondrial-derived danger signals released during cold ischemic storage activate endothelium and influence early graft function in liver transplantation | ALBERTO BAROJA-MAZO | ![]() |
![]() |
|||
eP-073 | In vitro and in vivo study on Recurrence after Liver Transplantation: MALAT1 Promotes Aggressive Hepatocellular Carcinoma Proliferation, Invasion and Recurrence | Secil Ak Aksoy | ![]() |
![]() |
|||
eP-074 | Liver-derived MSCs Are Superior in Reducing Inflammation In Vivo | Yun Liang | ![]() |
![]() |
|||
eP-077 | Normothermic machine-perfused human donor livers produce functional hemostatic proteins | Silke Bodewes | ![]() |
![]() |
|||
eP-081 | Rejuvenation of diseased liver using gelatin-based scaffolds using the immunomodulatory property of mesenchymal stem cells. | Catherine Ann Martin | ![]() |
![]() |
|||
eP-084 | Testing HepatoPredict kit performance in liver transplantation prognosis for hepatocellular carcinoma when facing intra- and inter-tumoral heterogeneity | Joana Cardoso | ![]() |
![]() |
|||
eP-089 | NEW NON-INVASIVE MARKERS OF PORTAL HYPERFLOW AND ITS ROLE IN CIRRHOSIS AND POST-LIVER TRANSPLANT OUTCOME | Eloisa Franchi | ![]() |
![]() |
|||
eP-090 | Emergency Liver Retransplantation with Marginal Donors | María Josefa Cuevas | ![]() |
![]() |
|||
eP-091 | A new metabolic comorbidity score predicts risk of death among cirrhotic patients on waiting list for liver transplantation | Simona Parisse | ![]() |
![]() |
|||
eP-092 | Impact of Donor Allograft Hepatocyte Necrosis on Liver Transplant Outcomes | Chi Zhang | ![]() |
![]() |
|||
eP-094 | High Rate of Early HEV Seroconversion after Liver Transplantation among Cirrhotic Patients | Alessandra Mazzola | ![]() |
![]() |
|||
eP-95 | Predictive equations underestimate measured energy expenditure in patients awaiting liver transplant | Brooke Chapman | ![]() |
![]() |
|||
eP-099 | Machine learning for the prediction of long-term graft survival following liver transplantation | Katina Zheng | ![]() |
![]() |
|||
eP-100 | Positive antibody response in liver transplant recipients on mycophenolate mofetil after the third, fourth and fifth SARS-CoV-2 vaccination; an observational cohort study | Midas Mulder | ![]() |
![]() |
|||
eP-101 | FRAILTY CHANGES AFTER LIVER TRANSPLANTATION IN THE SPANISH SETTING. RESULTS FROM A SPANISH MULTICENTRE PROSPECTIVE COHORT STUDY | Lorena Puchades | ![]() |
![]() |
|||
eP-102 | What are risk factors for graft mortality in patients who underwent simultaneous splenectomy during living-donor liver transplantation? | Takeo Toshima | ![]() |
![]() |
|||
eP-103 | Assessment of silent coronary artery disease with functional and anatomic tests in liver transplantation: analysis of the diagnostic and prognostic performance of a risk-adapted protocol | Giulia Pagano | ![]() |
![]() |
|||
eP-104 | Phosphatidylethanol as a marker for the diagnosis of alcohol relapse after liver transplantation: single centre experience | SVETLANA ADAMCOVA SELCANOVA | ![]() |
![]() |
|||
eP-106 | Patient Selection Factors for Fast-Track Extubation After Adult Liver Transplantation: A Step Towards Precision Medicine in Transplantation | Gen Yi Peng | ![]() |
![]() |
|||
eP-107 | LONG-TERM OUTCOME OF CENTENARIAN LIVERS | Francesco Tandoi | ![]() |
![]() |
|||
eP-108 | Very low access to early liver Transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications | Victoria Aguilera | ![]() |
![]() |
|||
eP-110 | Donor atherosclerosis is the main driver of hepatic artery thrombosis after liver transplantation | Javier Manuel Zamora Olaya | ![]() |
![]() |
|||
eP-111 | De Novo Tumors in Liver Transplantation Recipients | Carmen BERNAL | ![]() |
![]() |
|||
eP-112 | 10-Year Outcomes for Patients Transplanted for Hepatocellular Carcinoma Beyond University of California, San Francisco Criteria | Sudha Kodali | ![]() |
![]() |
|||
eP-113 | Early major bleeding after liver transplant affects long term survival: identification of risk factors | Alessandro Galli | ![]() |
![]() |
|||
eP-114 | EVOLUTION AND IMPACT OF SARCOPENIA BEFORE AND AFTER LIVER TRANSPLANTATION | Jerome Dumortier | ![]() |
![]() |
|||
eP-116 | EFFECTIVENESS OF NOREPINEPHRINE INFUSION PROTOCOL IN ACHIEVING THE RESOLUTION OF HEPATORENAL SYNDROME | Alexandra Shingina | ![]() |
![]() |
|||
eP-117 | Outcomes of Adult Liver Transplantation for Acute Liver Failure; A 15-Year Experience in a Single Center | Geunhyeok Yang | ![]() |
![]() |
|||
eP-118 | De novo Metabolic Syndrome after Liver Transplantation: A Meta-Analysis on Cumulative Incidence, Risk Factors, and Outcomes | Wen Hui Lim | ![]() |
![]() |
|||
eP-119 | Open abdomen management in liver transplantation | Takanobu Hara | ![]() |
![]() |
|||
eP-122 | POST-TRANSPLANT OUTCOMES OF LIVER TRANSPLANT RECIPIENTS WITH HEPATIC SARCOIDOSIS: A MATCHED CASE-CONTROL STUDY | Saam Dilmaghani | ![]() |
![]() |
|||
eP-123 | Single-center experience with upper midline incision liver transplant (MILT): a case-matched study | Yogesh Puri | ![]() |
![]() |
|||
eP-124 | Impact of Cirrhotic Cardiomyopathy and its Echocardiographic Components on Intraoperative and Perioperative Outcomes after Liver Transplantation | Ashley Cozart | ![]() |
![]() |
|||
eP-125 | INCIDENCE OF DE NOVO SKIN AND NON-SKIN CANCER AFTER LIVER TRANSPLANTATION IN A WESTERN COUNTRY: A LONG-TERM OBSERVATIONAL STUDY | Cristina Dopazo | ![]() |
![]() |
|||
eP-126 | Structural and functional cardiac abnormalities in liver cirrhosis. A single-centre experience | Charles Panackel | ![]() |
![]() |
|||
eP-129 | Late-Onset Steatosis May Affect Post-Liver Transplant Survival in Patients with Non-Alcoholic Steatohepatitis Cirrhosis | David Victor | ![]() |
![]() |
|||
eP-130 | Utilization of Hepatitis C Virus-Positive Organs for Transplant: A Single-Center Experience | Sudha Kodali | ![]() |
![]() |
|||
eP-131 | Loco-Regional Bridging Therapy for Hepatocellular Carcinoma: A Cost-Analysis Study Using National Registries | Govind Rangrass | ![]() |
![]() |
|||
eP-132 | Factor V (FV) as a predictor of Graft Loss After Liver Transplant | Marco Claasen | ![]() |
![]() |
|||
eP-134 | A single-center analysis of gender mismatched liver transplantation in a high-volume transplant center in North America | Catherine Parmentier | ![]() |
![]() |
|||
eP-135 | Artificial intelligence enhanced electrocardiogram prediction of atrial arrhythmia in patients undergoing liver transplantation | Induja Reddy Nimma | ![]() |
![]() |
|||
eP-138 | In liver transplant recipients the humoral and cellular immune response after the 4th SARS-CoV-2 vaccination is lower than after a breakthrough infection | Martina Sterneck | ![]() |
![]() |
|||
eP-139 | PRIMARY SCLEROSING CHOLANGITIS AS AN INDICATION FOR LIVER TRANSPLANTATION. RESULTS AND CONDITIONING FACTORS: RELATIONSHIP WITH ASSOCIATED INTESTINAL PATHOLOGY | Ainhoa Fernández | ![]() |
![]() |
|||
eP-142 | Cardiac Power as a Predictor of Perioperative Outcomes in Liver Transplantation | Ruth Bickett-Hickok | ![]() |
![]() |
|||
eP-143 | Liver transplantation: a 10-year low-volume transplant center experience in Kazakhstan | Abylaikhan Sharmenov | ![]() |
![]() |
|||
eP-144 | OUTCOMES AFTER LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: INITIAL EXPERIENCE FROM VIETNAM | Dang Do Hai | ![]() |
![]() |
|||
eP-146 | Biliary reconstruction for multiple graft bile ducts does not impact posttransplant outcomes compared with single graft bile duct after living donor liver transplantation | Joodong Kim | ![]() |
![]() |
|||
eP-148 | Clinical, Demographic and Social Risk Factors Associated with COVID-19 Mortality among Liver Transplant Recipients in the United States | Yanik Bababekov | ![]() |
![]() |
|||
eP-149 | Clinical relevance of the interval from transplantation to therapeutic through concentrations of tacrolimus | Paloma Elma Alañón Martínez | ![]() |
![]() |
|||
eP-150 | The Role of Roux-en-Y Hepaticojejunostomy for the Management of Biliary Complications after Living Donor Liver Transplantation | Tzu-Cheng Wen | ![]() |
![]() |
|||
eP-151 | Liver Retransplantation a Twenty Year, Single Center Experience | Onur Ibanoglu | ![]() |
![]() |
|||
eP-152 | Distinct features and outcomes of patients with primary sclerosing cholangitis included on the waiting list for liver transplantation in Romania | Speranta Iacob | ![]() |
![]() |
|||
eP-153 | Perioperative Outcomes of Immediate Extubation Following Liver Transplantation: Inverse Probability of Treatment-Weighted Analyses | Gen Yi Peng | ![]() |
![]() |
|||
eP-154 | Left ventricular geometry is not associated with acute kidney injury following liver transplantatiojn | Peter Frasco | ![]() |
![]() |
|||
eP-156 | De novo and recurrence of NAFLD/NASH after liver transplantation and the impact of immunosuppressants: systematic review, meta-analysis and experimental exploration | Yining Wang | ![]() |
![]() |
|||
eP-157 | Combining Skeletal Muscle Index with Liver Frailty Index improves mortality prediction in patients with cirrhosis awaiting liver transplantation | Kamal Yadav | ![]() |
![]() |
|||
eP-158 | IS LIVER TRANSPLANTATION DIFFICULTY PREDICTIBLE ? | Simon ROUCAUTE | ![]() |
![]() |
|||
eP-160 | Indication of liver transplantation in the treatment of newly categorized acute-on-chronic liver failure in Japan | Kaori Kuramitsu | ![]() |
![]() |
|||
eP-161 | Low hepatic artery resistive index on the first post- liver transplant day is associated with inferior graft survival | Flavia Feier | ![]() |
![]() |
|||
eP-162 | Pregnancy and childbirth after liver transplantation in our hospital | Takashi Ito | ![]() |
![]() |
|||
eP-163 | Pretransplant Diabetes Mellitus Predicts Worse Outcomes of Liver Transplantation: An Updated Meta-analysis and Systematic Review | Wen Hui Lim | ![]() |
![]() |
|||
eP-165 | LIVER TRANSPLANTATION AFTER IVERMECTIN USE AND POST-COVID19 CHOLANGIOPATHY | Ilka Boin | ![]() |
![]() |
|||
eP-166 | Incidence of de novo tumors after liver Transplantation (LT) in HIV infected is similar to non-HIV patients: A Single Center Comparative Study | Carmen Vinaixa | ![]() |
![]() |
|||
eP-167 | Gender Impact on the Outcomes of Deceased Donor Liver Transplantation | Taryn Kedzior | ![]() |
![]() |
|||
eP-168 | Transjugular intrahepatic portosystemic shunt insertion as a therapy for portal hypertension improves cirrhosis-associated immune dysfunction | Penelope Hey | ![]() |
![]() |
|||
eP-169 | Utility of an active screening program of urine ethylglucuronide determination for confirmation of alcohol withdrawal prior to inclusion in the waiting list for liver transplantation | Patricio Más-Serrano | ![]() |
![]() |
|||
eP-170 | Successful Liver Transplantation in a Patient with Preoperative Takotsubos Cardiomyopathy: A Case Report | Alexandra Ruan | ![]() |
![]() |
|||
eP-172 | Treatment for vascular complications utilizing a hybrid operation room after liver transplantation | Hiroyuki Hakoda | ![]() |
![]() |
|||
eP-173 | Outcome of patients waitlisted for Deceased Donor Liver transplantation during COVID-19 pandemic - A Single centre experience | Dinesh Jothimani | ![]() |
![]() |
|||
eP-174 | The patient experience of the liver transplant evaluation process and potential implications related to waitlist access | Alexandra Strauss | ![]() |
![]() |
|||
eP-175 | Combined Coronary Artery Bypass Grafting and Living Donor Liver Transplant formidable but possible | FYSAL KOLLANTA VALAPPIL | ![]() |
![]() |
|||
eP-178 | DOES COLECTOMY IMPROVE SURVIVAL IN PATIENTS WITH ULCERATIVE COLITIS UNDERGOING LIVER TRANSPLANT FOR AUTOIMMUNE LIVER DISEASES? | Victoria Aguilera | ![]() |
![]() |
|||
eP-183 | Long-term risk of de novo solid organ malignancy: a 28-year experience oriented to living donor liver transplantation | Kosuke Tanaka | ![]() |
![]() |
|||
eP-186 | Liver allograft neovascularization after arterial thrombosis. Experience at the National Institute of Medical Sciences and Nutrition Salvador Zubirán in Mexico City | Catherine Parmentier | ![]() |
![]() |
|||
eP-187 | Hepatocellular carcinoma: segmental distribution in cirrhotic livers | Ilka Boin | ![]() |
![]() |
|||
eP-188 | Successful Liver Transplantation in a Patient with Alstrom Syndrome and Cardiomyopathy: A Case Report | Alexandra Ruan | ![]() |
![]() |
|||
eP-189 | CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatation (LT) | Victoria Aguilera | ![]() |
![]() |
|||
eP-190 | Safety and efficacy of Direct Oral Anticoagulants in liver transplant recipients: Initial experience | Narendra S Choudhary | ![]() |
![]() |
|||
eP-191 | The experience of management for biliary complication after liver transplant in small volume center | Min-Jae KIM | ![]() |
![]() |
|||
eP-192 | The Factors of Predicting Over-Time Weight Increase After Liver Transplantation | Yuhi Shimura | ![]() |
![]() |
|||
eP-193 | Combined heart liver kidney transplantation: a pioneer experience in South America | Munique Siqueira | ![]() |
![]() |
|||
eP-194 | The need for an artificial kidney for long-term NMP of human donor livers up to one week | Bianca Lascaris | ![]() |
![]() |
|||
eP-195 | Development of an Extended Liver Normothermic Machine Perfusion Protocol | George Clarke | ![]() |
![]() |
|||
eP-196 | N-acetylcysteine: A Novel Approach to Methaemoglobinaemia in Normothermic Liver Machine Perfusion | George Clarke | ![]() |
![]() |
|||
eP-197 | Outcomes of liver retransplantation from donation after circulatory death livers using normothermic regional perfusion | Christopher Watson | ![]() |
![]() |
|||
eP-198 | In situ and ex situ dynamic preservation versus cold storage in liver transplantation from older donation after circulatory death donors | Joris Blondeel | ![]() |
![]() |
|||
eP-199 | Occult fibrin in deceased donor livers is associated with transplant failure and cholangiopathy | Christopher Watson | ![]() |
![]() |
|||
eP-201 | Achieving Long-Term Liver Preservation: Integration of a Dialysis System to a Commercial Normothermic Perfusion System | Joanna Huang | ![]() |
![]() |
|||
eP-202 | The risk of microbial infection in recipients of donor livers that underwent hypothermic or normothermic machine perfusion | Chikako Endo | ![]() |
![]() |
|||
eP-203 | Coagulation and fibrinolysis markers during normothermic liver perfusion offer insights into vascular integrity and preservation injury | Jule Dingfelder | ![]() |
![]() |
|||
eP-204 | Trends and obstacles to implement dynamic perfusion concepts for clinical liver transplantation: Results from an international survey | Alessandro Parente | ![]() |
![]() |
|||
eP-205 | Quantified FMN perfusate levels correlate with early allograft dysfunction during hypothermic liver machine perfusion | Sertac Kacar | ![]() |
![]() |
|||
eP-207 | OUTCOMES OF LIVER TRANSPLANTATION WITH THORACOABDOMINAL NORMOTHERMIC REGIONAL PERFUSION FOR HEART DONATION | Luis Secanella | ![]() |
![]() |
|||
eP-210 | Optimization of ex vivo normothermic liver perfusion through the addition of (un)conjugated bile acids | Lianne Stevens | ![]() |
![]() |
|||
eP-211 | NORMOTHERMIC MACHINE PERFUSION IN HIGH-RISK EXTENDED CRITERIA DONORS: RESULTS FROM LARGE MONOCENTRIC EXPERIENCE | fabio melandro | ![]() |
![]() |
|||
eP-212 | Favourable outcomes with hypothermic oxygenated machine perfusion in donation after circulatory death liver transplants a single centre experience | James Walcott | ![]() |
![]() |
|||
eP-213 | An Add-On Automated Blood Gas System for Ex Vivo Normothermic Machine Perfusion | Daniel Babekuhl | ![]() |
![]() |
|||
eP-216 | Early liver transplant failure after normothermic perfusion: Not everything ends well | Rohit Gaurav | ![]() |
![]() |
|||
eP-218 | Proof of concept for clinical application of machine perfusion to extended criteria donor grafts in Japan | Akihiko Soyama | ![]() |
![]() |
|||
eP-221 | Role of pre-operative steroids on liver IRI in DCD liver transplantation | Shekhar Kubal | ![]() |
![]() |
|||
eP-223 | A pilot comparison of two devices for liver normothermic machine perfusion in clinical transplantation | Qiang Liu | ![]() |
![]() |
|||
eP-224 | Impact of Normothermic Machine Perfusion on Abdominal Transplant Fellowship Training | Mignote Yilma | ![]() |
![]() |
|||
eP-225 | Ex situ fibrinolytic therapy during normothermic perfusion before transplantation clears intravascular fibrin and is associated with minimal cholangiopathy | Christopher Watson | ![]() |
![]() |
|||
eP-226 | Hypothermic oxygenated perfusion (HOPE) using an ECMO device with FMN levels measurement and thermographic images for liver graft assessment and transplantation | Elizabeth Rivas | ![]() |
![]() |
|||
eP-227 | Ultra-rapid harvesting method for liver graft from donor after cardiac death | Eiji Kobayashi | ![]() |
![]() |
|||
eP-229 | The role of normothermic machine perfusion in large liver grafts | Beatrice Cazzaniga | ![]() |
![]() |
|||
eP-230 | Machine-perfusion for liver transplantation in high-volume centres versus low/mid-volume centres: an international multicentre survey | Roberta Angelico | ![]() |
![]() |
|||
eP-232 | Excellent Outcomes Despite Prolonged Graft Preservation Times: Early Single Center Experience with Portable Normothermic Machine Perfusion in DCD Liver Transplantation | Mark Hobeika | ![]() |
![]() |
|||
eP-235 | Impact of Normothermic Machine Perfusion in liver transplantation with donors after circulatory death: a single-center experience | Emmanuel Nogueira | ![]() |
![]() |
|||
eP-237 | Machine Perfusion Preservation of DCD livers is associated with Increased DRI: Data from the UNOS/SRTR Database | Peter Abt | ![]() |
![]() |
|||
eP-238 | Liver assessment method with flow dynamics index during subnormothermic machine perfusion | Hiromichi Obara | ![]() |
![]() |
|||
eP-239 | Impact of a novel flush method using environmental pressure control for organs from donor after cardiac death | Syuhei Yoshimoto | ![]() |
![]() |
|||
eP-240 | Normothermic machine perfusion preservation on livers from donors after circulatory death | Qiang Liu | ![]() |
![]() |
|||
eP-242 | Dual hypothermic oxygenated perfusion (D-HOPE) of liver grafts from ECD donors after brain death initial experience in the single center of Medical University of Warsaw | Piotr Niecikowski | ![]() |
![]() |
|||
eP-244 | VALIDATION OF MELD3.0 IN TWO CENTRES FROM DIFFERENT CONTINENTS | Marta Tejedor | ![]() |
![]() |
|||
eP-245 | Biomarkers during orphan liver normothermic machine perfusion: who is more reliable to predict post-transplant outcomes? | Qiang Liu | ![]() |
![]() |
|||
eP-246 | Performance of the Gender-Equity Model for Liver Allocation (GEMA-Na) within the first 30 and 60 days of listing | Manuel Rodríguez-Perálvarez | ![]() |
![]() |
|||
eP-247 | Donor Diabetes and Steatosis Affects Recipient Survival Following Liver Transplantation based on Etiology of Liver Cirrhosis | Wen Hui Lim | ![]() |
![]() |
|||
eP-250 | Outcomes of Transplantation of Hepatitis B NAT Positive Organs for Hepatitis B Seronegative Recipients of Liver Transplants | Julie Giannini | ![]() |
![]() |
|||
eP-251 | Machine-Learning-Assisted Donor-Recipient Matching for Orthotopic Liver Transplantation | Miran Bezjak | ![]() |
![]() |
|||
eP-252 | Retransplantation using living donor grafts: who are reasonable applicants? | Kosuke Tanaka | ![]() |
![]() |
|||
eP-253 | Transplants for HCC. Do radiologists and pathologists agree? | James Vassallo | ![]() |
![]() |
|||
eP-254 | Outcomes of Re-Referrals for Patients With Alcohol-Related Liver Disease Who Were Previously Declined for Liver Transplantation | Benjamin Cox | ![]() |
![]() |
|||
eP-255 | Ethnic Disparities in Waitlist Outcomes of Non-alcoholic Steatohepatitis Listed for Liver Transplantation in the United States | Wen Hui Lim | ![]() |
![]() |
|||
eP-256 | National and Regional Trends in Liver Transplant Exception Points After Allocation Policy Change | Taryn Kedzior | ![]() |
![]() |
|||
eP-257 | Quantification of Mitochondrial Dysfunction Surrogates in Flushing Solution to Assess Donor Livers Pre Transplantation | Khaled Ali | ![]() |
![]() |
|||
eP-258 | ACCESS TO LIVER TRANSPLANT FOR WOMEN IN SPAIN: A NATIONAL REGISTRY ANALYSIS | Marta Tejedor | ![]() |
![]() |
|||
eP-259 | Impact of extended living donor crirteria on donor safety in living donor liver transplantation | Joodong Kim | ![]() |
![]() |
|||
eP-261 | A simple noninvasive index can predict liver graft discard in marginal donors | Sergio Cortese | ![]() |
![]() |
|||
eP-264 | Increasing Access to Transplantation for Hispanic Patients Through an Integrative Pilot Spanish Speaking Liver Transplant Program | Blanca Lizaola-Mayo | ![]() |
![]() |
|||
eP-265 | Modernizing the Concept of Donor Risk Index (DRI): DBD-DRI and DCD-DRI Scores to Predict Liver Graft Survival | Yanik Bababekov | ![]() |
![]() |
|||
eP-266 | Identifying Ideal Liver Candidates for Donation after Cardiac Death Transplants | Yanik Bababekov | ![]() |
![]() |
|||
eP-267 | A Web Calculator to Predict Progression to Cardiac Death within 30 Minutes of Potential DCD Donors Using DonorNet | Yanik Bababekov | ![]() |
![]() |
|||
eP-269 | Overview of liver organ allocation policies in Europe and the impact on outcome after liver transplantation | Xavier Verhelst | ![]() |
![]() |
|||
eP-270 | Characterization and Evolution of Caregiver Burden Among Caregivers of Liver Transplant Recipients | Kymberly Watt | ![]() |
![]() |
|||
eP-272 | Discrimination ability of post liver transplant mortality in acute-on-chronic liver failure: MELD-Na versus CLIF-C ACLF score | Jae Hwan Kim | ![]() |
![]() |
|||
eP-273 | Liver-centered acute-on-chronic liver failure is not associated with improved survival after liver transplantation | Joris Blondeel | ![]() |
![]() |
|||
eP-274 | Impact Of Organ Allocation Policy Change In Simultaneous Liver Kidney Organ Transplant In The Unites States: An Institutional Experience | Lydia Mercado | ![]() |
![]() |
|||
eP-275 | Effectiveness of DEI Committees Outreach Program at a Single Center Serving a Large Hispanic Population | Sudha Kodali | ![]() |
![]() |
|||
eP-276 | National Trends in Liver Transplant After Allocation Policy Change with a Focus on Diversity | Taryn Kedzior | ![]() |
![]() |
|||
eP-277 | Up-regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation | Takahiro Tomiyama | ![]() |
![]() |
|||
eP-278 | DEMOGRAPHIC AND SOCIOECONOMIC DISPARITIES CONTINUES TO PERSIST IN PATIENTS LISTED FOR LIVER TRANSPLANTATION IN THE POST-SHARE 35 POLICY ERA | Mignote Yilma | ![]() |
![]() |
|||
eP-279 | Impact of the UNOS Acuity Circles Liver Allocation Policy on Waitlist Dropout at a High Volume Center | Eduardo Fernandes | ![]() |
![]() |
|||
eP-280 | Systematic Review and Meta-Analysis of Factors Affecting Survival after Liver Retransplantation | Elizabeth Brombosz | ![]() |
![]() |
|||
eP-282 | Current Practices and Perceptions of Ex Vivo Liver Machine Perfusion in the United States | Chi Zhang | ![]() |
![]() |
|||
eP-283 | A risk factor analysis of donor-specific factors on one- and three-year post-transplant mortality after multi visceral transplantation | Tommy Ivanics | ![]() |
![]() |
|||
eP-284 | Risk Factors for Mortality after Receiving a Liver Graft from an Older Donor | Elizabeth Brombosz | ![]() |
![]() |
|||
eP-285 | CHANGING INDICATIONS FOR LIVER TRANPLANTATION IN THE ERA OF DAA. RETROSPECTIVE ANALYSIS OF DATA OF A LIVER TRANPLANT CENTER | Donatella Pisaniello | ![]() |
![]() |
|||
eP-286 | Spontaneous Gall bladder rupture in a patient with Decompensated Cirrhotic identified at Transplantation | sorabh kapoor | ![]() |
![]() |
|||
eP-287 | ROLE OF A NURSE WITHIN AN ORGAN DONATION PROGRAMME IN THE INTENSIVE CARE UNIT | Mateja afar | ![]() |
![]() |
|||
eP-288 | ANALYSIS OF DONOR ORGAN FACTORS IN EARLY POST-TRANSPLANT HEPATOCARCINOMA RECURRENCE | Miguel Jimenez Perez | ![]() |
![]() |
|||
eP-289 | Assessment of persistent COVID-19 in liver transplant recipients compared to immunocompetent individuals | Ainhoa Fernández | ![]() |
![]() |
|||
eP-293 | Predictive factors of antibody response after anti-SARS-CoV-2 vaccine in liver transplant recipients | Audrey Coilly | ![]() |
![]() |
|||
eP-294 | Vancomycin-Resistant Enterococcus Bloodstream Infections After Liver Transplantation | Max Adelman | ![]() |
![]() |
|||
eP-295 | Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring: the randomized controlled FK04 trial | Bastian Ruijter | ![]() |
![]() |
|||
eP-298 | Long-term results of ab-initio introduction of Everolimus after liver transplantation | Domiziana Pedini | ![]() |
![]() |
|||
eP-299 | Eight-week post-transplant treatment of HCV-negative kidney recipients from HCV-viremic donors with glecaprevir/pibrentasvir is as effective as twelve-week treatment | Benyam Addissie | ![]() |
![]() |
|||
eP-300 | DEVELOPMENT OF CARDIOVASCULAR COMPLICATIONS RELATED TO IMMUNOSUPPRESSIVE REGIMEN | CARMEN ALONSO-MARTIN | ![]() |
![]() |
|||
eP-301 | Liver Transplantation outcomes in patients following COVID-19 infection | Radhika Venugopal | ![]() |
![]() |
|||
eP-302 | Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-COV-2 in the immediate post liver transplant period | Flavia Feier | ![]() |
![]() |
|||
eP-303 | The impact of Organ/Space Surgical Site Infections (OSSI) on outcome after deceased donor liver transplant | Femke de Goeij | ![]() |
![]() |
|||
eP-304 | A multi-centre non-interventional study to assess the tolerability and effectiveness of extended-release tacrolimus (LCPT) in de novo liver transplant patients | Gabriela Berlakovich | ![]() |
![]() |
|||
eP-305 | RESPONSE TO COVID-19 VACCINATION AND CONTIXAGEVIMAB-CILGAVIMAB PROPHYLAXIS IN PATIENTS UNDERGOING LIVER AND KIDNEY TRANSPLANTATION: PRELIMINARY STUDY | Domiziana Pedini | ![]() |
![]() |
|||
eP-306 | Selective intestinal decolonization and antibiotic treatment of Carbapenem-Resistant Enterobacteriaceae in pediatric and adult liver transplant recipients | Sunitha Vimalesvaran | ![]() |
![]() |
|||
eP-307 | Outcomes and mortality of early SARS-CoV-2 infection in liver transplant recipients of a large volume transplant center in Latin America | Jorge Arturo Martinez | ![]() |
![]() |
|||
eP-308 | SURVIVAL AFTER COVID-19 IN UNVACCINATED LIVER TRANSPLANT RECIPIENTS ACCORDING TO DISEASE WAVES - RESULTS FROM A BRAZILIAN MULTICENTRIC STUDY | Ilka Boin | ![]() |
![]() |
|||
eP-309 | Role of antithymocyte globulin based induction immunosuppression in adult liver transplantation | Shekhar Kubal | ![]() |
![]() |
|||
eP-310 | A Case of Mixed Chronic Rejection and Recidivism treated with Everolimus and Lifestyle Modifications | Hirak Pahari | ![]() |
![]() |
|||
eP-312 | Technical feasibility and outcome of Salvage living donor liver transplantation after major hepatectomy | Young-In Yoon | ![]() |
![]() |
|||
eP-316 | Should We Reconstruct Both Hepatic Arteries in Right Lobe Grafts with Two Hepatic Arteries? | Sung Min Kim | ![]() |
![]() |
|||
eP-319 | The Gift of Life in Solid Organ Transplantation: A Qualitative Systematic Review of Altruistic Living Donors Perspectives | Wen Hui Lim | ![]() |
![]() |
|||
eP-320 | Impact of baseline anti-ABO antibody titer on biliary complications following ABO-incompatible living donor liver transplantation | Dong-Sik Kim | ![]() |
![]() |
|||
eP-321 | Long-term Clinical Outcomes and Predictive Factors for Living-donor Liver Transplant Recipients With acute liver failure | DongHwan Jung | ![]() |
![]() |
|||
eP-322 | Effect of the response to preoperative treatment for hepatorenal syndrome on the outcome of recipients of living-donor liver transplantation | Ryugen Takahashi | ![]() |
![]() |
|||
eP-323 | Effect of Desensitization Protocol According to the Degree of Antibody Mediated Rejection Risk in Living Donor Liver Transplant; Retrospective Cohort Study | YoungRok Choi | ![]() |
![]() |
|||
eP-325 | Pre-operative percutaneous portal vein recanalization and transjugular intrahepatic portosystemic shunt makes living donor liver transplantation feasible in extensive porto-mesenteric thrombosis | Fysal Kollanta Valappil | ![]() |
![]() |
|||
eP-327 | SINGLE-CENTER RETROSPECTIVE ANALYSIS OF THORACIC EPIDURAL ANALGESIA IN DONOR HEPATECTOMIES- AN EXPERIENCE OF OVER A DECADE | Nikunj Gupta | ![]() |
![]() |
|||
eP-329 | Initial high anti-ABO isoagglutinin titer is a major red flag of bacterial infection in ABO-incompatible living donor liver transplantation | Mun Chae Choi | ![]() |
![]() |
|||
eP-330 | The evolution of robotic donor hepatectomy as standard of care at a high volume living donor liver transplant center | Kamal Yadav | ![]() |
![]() |
|||
eP-331 | Total robotic right lobe donor hepatectomy and recipient surgery via a midline incision: small cuts no longer a big dream in living donor liver transplantation | Kamal Yadav | ![]() |
![]() |
|||
eP-332 | GM diet: a quick fix for steatotic live liver donors | Anish Gupta | ![]() |
![]() |
|||
eP-333 | Post-donation regret, family relationships, and depression in living liver donors: a mediation model | Ye Sol Lee | ![]() |
![]() |
|||
eP-341 | Impact of three-dimensional thoracic shape on the surgical outcomes of minimally invasive living donor hepatectomy | Kosuke Tanaka | ![]() |
![]() |
|||
eP-343 | Effect of adding congested segment ? to left lateral graft on short-term outcomes in pediatric living donor liver transplant recipients | Hikaru Aoki | ![]() |
![]() |
|||
eP-344 | Older Living Liver Donors can enlarge the Donor Pool: A Systematic Review and Meta-Analysis | Hayo Ter Burg | ![]() |
![]() |
|||
eP-345 | Living Donor Liver Transplant Trends in the Era of Acuity Circle Allocation in the United States | Alexandra Shingina | ![]() |
![]() |
|||
eP-346 | Donor BMI Has No Impact on Post-Operative Outcomes in Living Donor Liver Transplantation | Reed Jenkins | ![]() |
![]() |
|||
eP-347 | UTILITY OF HEPARIN PROPHYLAXIS AND PERIOPERATIVE VASCULAR THROMBOSIS AFTER PEDIATRIC LIVER TRANSPLANTATION | Ampaipan Boonthai | ![]() |
![]() |
|||
eP-349 | Left Lobe procurement based on intraoperative portal pressure measurement and its impact on outcome | Rajesh Dey | ![]() |
![]() |
|||
eP-350 | A successful rescue procedure of in situ graft volume reduction for accommodation to the small abdominal cavity during pediatric living donor liver transplantation | Yasuhiro Ogura | ![]() |
![]() |
|||
eP-351 | Impact of short-term weight reduction program for steatotic graft or high BMI donor on the outcome of living-donor liver transplantation | Hye-Sung Jo | ![]() |
![]() |
|||
eP-352 | Development of Metabolic Disorders in Liver Transplant Recipients | Gizem Erdemir | ![]() |
![]() |
|||
eP-354 | Perioperative risk factors for early bacteremia and sepsis following living donor liver transplantation (LDLT) | Devika Pradeep | ![]() |
![]() |
|||
eP-357 | Biliary strictures after pediatric living donor liver transplantation analysis of incidence, risk factors, management and outcome | Mateusz Ciopi&324;ski | ![]() |
![]() |
|||
eP-358 | Impact of RhD blood group mismatch in Living Donor Liver transplantation | Dinesh Jothimani | ![]() |
![]() |
|||
eP-359 | An intention-to-treat analysis of live donor liver transplantation vs. deceased donor liver transplantation for patients with alcoholic liver disease | Owen Jones | ![]() |
![]() |
|||
eP-366 | Migration of Polytetrafluoroethylene graft used for neo-middle hepatic vein reconstruction in living donor liver transplant recipients case series | Akash Selvathangam | ![]() |
![]() |
|||
eP-368 | Transition from open- to robot-assisted donor right hepatectomy program for adult to adult living liver donation: early outcomes and lessons learned | Michele Finotti | ![]() |
![]() |
|||
eP-371 | Does the option of robotic donor hepatectomy positively influence willingness for live liver donation? | Kamal Yadav | ![]() |
![]() |
|||
eP-372 | International Living Donor Liver Transplant Registry | LDLTregistry.org | Camila Hidalgo Salinas | ![]() |
![]() |
|||
eP-373 | Building a donor pool for acute liver failure through unrelated undirected donation in the Middle East | Maren Schulze | ![]() |
![]() |
|||
eP-374 | Aberrant Totally Extrahepatic Right Hepatic Duct in Live Liver Donors | Safa Vatansever | ![]() |
![]() |
|||
eP-375 | Living donor liver transplantation for samll ducts intrahepatic cholangiocarcinoma with neoadjuvant chemotherapy: a pioneer experience in South America | Munique Siqueira | ![]() |
![]() |
|||
eP-376 | Methylene Blue during living donor liver transplantation - Case series - | Myungsuk Kim | ![]() |
![]() |
|||
eP-379 | Liver Retransplantation Indications and Technical Approaches in Post Hepatitis C Era | Rolf Barth | ![]() |
![]() |
|||
eP-380 | Outcome of 40 LDLT in a newly established adult living donor liver transplant program in the Netherlands | Robert Minnee | ![]() |
![]() |
|||
eP-381 | Impact of Medicaid Expansion on Liver Transplantation in the State of Oklahoma | Taryn Kedzior | ![]() |
![]() |
|||
eP-383 | Obliterative portal venopathy in biliary atresia: Histology of recipient portal veins replaced during living donor liver transplantation | Muthukumarassamy Rajakannu | ![]() |
![]() |
|||
eP-384 | Robotic living donor hepatectomy at University of Modena | Fabrizio Di Benedetto | ![]() |
![]() |
|||
eP-385 | Outcome of live liver donor who is 75 years old (case) | Geun Hong | ![]() |
![]() |
|||
eP-389 | Outcomes of LDLTs performed by the Georgian Liver Transplantation Center for 8 years | Kakhaber Kashibadze | ![]() |
![]() |
|||
eP-390 | Experiences and lessons learned from 427 living donors for liver transplantation | Kosei Takagi | ![]() |
![]() |
|||
eP-391 | FACTORS ASSOCIATED WITH EARLY VASCULAR COMPLICATIONS IN PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION | Ampaipan Boonthai | ![]() |
![]() |
|||
eP-392 | Single Dose Eculizumab as Desensitization Protocol For ABO-Incompatible Living Donor | Mario Spaggiari | ![]() |
![]() |
|||
eP-395 | Alteration of MELD score after plasmapheresis in ABO-incompatible living donor liver transplantation | Sukyoung Her | ![]() |
![]() |
|||
eP-396 | How could we establish the laparoscopic donor hepatectomy at a small volume center?; Our early experiences | Tae-Seok Kim | ![]() |
![]() |
|||
eP-397 | Graft Hepatic Artery Thrombosis in Living Donor Liver Transplantation from a COVID-19 Positive Donor | Vikram Raut | ![]() |
![]() |
|||
eP-398 | Ciliated Hepatic Foregut Cyst in the Explanted Liver of a Patient with Cryptogenic Cirrhosis | Rasim Farajov | ![]() |
![]() |
|||
eP-399 | The new generation of adult-to-adult living donor liver transplantations: towards all grafts and recipients alive after 12-months of median follow-up | Stefano Di Sandro | ![]() |
![]() |
|||
eP-400 | Liver Transplantation for Alcohol related liver disease in the era of Acute on chronic liver failure | Dinesh Jothimani | ![]() |
![]() |
|||
eP-401 | Donor outcome related to middle hepatic vein-sparing policy for donor hepatectomy in living donor liver transplantation | Kun-Ming Chan | ![]() |
![]() |
|||
eP-402 | Extraanatomic anatomic jump graft using great saphenous vein | Yang-Seok Koh | ![]() |
![]() |
|||
eP-403 | The Changing Face of Hepatocellular Carcinoma In Children | Sergio Assia-Zamora | ![]() |
![]() |
|||
eP-404 | Similar long-term outcome achieved with live donor and split deceased donor left liver grafts in paediatric liver transplantation | John McCall | ![]() |
![]() |
|||
eP-405 | Validation of prognotic prediction of Early allograft dysfunction models on Small Grafts in Pediatric liver transplantation | Jasper Sandeep Rajasekar | ![]() |
![]() |
|||
eP-406 | Surveillance liver biopsy in paediatric living donor liver transplantation from young donors - How is east different from the west? | Neelam Mohan | ![]() |
![]() |
|||
eP-407 | Prognostic impact of concurrent portal vein thrombosis in pediatric late liver re-transplantation | Riccardo Cirelli | ![]() |
![]() |
|||
eP-410 | Auxiliary partial orthotopic liver transplantation for metabolic disease in children: single centre experience | Miriam Cortes-Cerisuelo | ![]() |
![]() |
|||
eP-412 | Paediatric domino-liver transplantation for maple syrup urine disease | Arianna Trizzino | ![]() |
![]() |
|||
eP-415 | Paediatric Intestinal Transplantation, Unique Indications And Surgical Innovations. Two Decade Experience In A Single Centre | Sergio Assia-Zamora | ![]() |
![]() |
|||
eP-416 | EHPVO in children under 2 years old. Diagnostic and treatment strategies, and their influence on outcome | Oleg Godik | ![]() |
![]() |
|||
eP-417 | First 550 paediatric liver transplants: Experience from high volume paediatric liver transplant program in India | Naresh Shanmugam | ![]() |
![]() |
|||
eP-420 | Deceased donor liver transplantation in pediatric patients: Experience at a single center in Japan performing mostly living donor liver transplantation | Yasuharu Onishi | ![]() |
![]() |
|||
eP-421 | Living-donor Liver Transplantation Using Segment 2 Monosegment and Reduced Left Lateral Grafts in Pediatric Cases. A Single-Center Experience | Remzi Emiroglu | ![]() |
![]() |
|||
eP-423 | Association of PELD score with perioperative and postoperative outcomes in pediatric liver transplantation | Pitthawat Julnipithawong | ![]() |
![]() |
|||
eP-426 | Pathologic and Immunophenotypic Characterization of Syncytial Giant Cell Variant of Pediatric Hepatocellular Carcinoma. A Distinct Subtype | Mukul Vij | ![]() |
![]() |
|||
eP-430 | Live Donor Liver Transplantation in an Infant with Pneumonia due to Active COVID-19 Infection | Zaza Iakobadze | ![]() |
![]() |
|||
eP-431 | Dual immune tolerance to both blood group antigen and donor graft: Case report | Soo Jin Na Choi | ![]() |
![]() |
|||
eP-432 | Large-for-size grafts in infant living donor liver transplantation - A mixed reality approach for preoperative planning | Zong Jie Koh | ![]() |
![]() |
|||
eP-433 | Trial in progress: Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients with Hepatocellular Carcinoma Beyond Milan Criteria | Maen Abdelrahim | ![]() |
![]() |
|||
eP-435 | Improving Access and Continuity of Care by Televideo Services During the COVID-19 Pandemic | Sudha Kodali | ![]() |
![]() |
|||
eP-436 | Should liver transplantation be offered to resectable patients with perihilar cholangiocarcinoma? | Eduardo Fernandes | ![]() |
![]() |
|||
eP-438 | INCREASING PREVALENCE OF LIVER TRANSPLANT RECIPIENTS WITH A HISTORY OF PRIOR MALIGNANCY LACKS CLEAR ASSOCIATION WITH DE NOVO MALIGNANCY RISK | Kymberly Watt | ![]() |
![]() |
|||
eP-439 | Treatment strategy for hepatocellular carcinoma recurrence in the transplant era: Focusing on the Japan criteria | Shohei Yoshiya | ![]() |
![]() |
|||
eP-441 | Entecavir versus tenofovir on the recurrence of hepatitis B virus related hepatocellular carcinoma after liver transplantation: a Korean nation-wide study | Hwa-Hee Koh | ![]() |
![]() |
|||
eP-442 | Nivolumab after Sorafenib failure in liver recipients with Hepatocellular carcinoma recurrence | Jieun Kwon | ![]() |
![]() |
|||
eP-443 | Implications of incidental hepatocholangiocarcinoma in the explant of patients undergoing liver transplantation | Muthukumarassamy Rajakannu | ![]() |
![]() |
|||
eP-444 | Radiologic Response of Hepatocellular Carcinoma to Single vs combination Locoregional therapy (Neoadjuvant Yttrium-90 and Y90Transarterial Chemoembolization) | Sudha Kodali | ![]() |
![]() |
|||
eP-445 | Salvage Living Donor Liver Transplantation for post resection HCC recurrence: Are outcomes comparable to upfront transplantation? | Prashant Bhangui | ![]() |
![]() |
|||
eP-447 | Iron secretion by hepatocyte exosomes via Rab27A drived ferroptosis of CD8 cells to promote post-transplant HCC recurrence | wang zhe | ![]() |
![]() |
|||
eP-448 | Trial in progress: Neoadjuvant Combination Therapy of Lenvatinib plus Transcatheter Arterial Chemoembolization (TACE) for Transplant-Eligible Patients with Large Hepatocellular Carcinoma | Maen Abdelrahim | ![]() |
![]() |
|||
eP-451 | Recurrence and survival following liver transplantation for Hepatocellular carcinoma without routine radiological surveillance | Bobby VM Dasari | ![]() |
![]() |
|||
eP-452 | Comparative Next generation sequencing analysis of Normal, Cirrhotic, and HCC tissue samples A step closer to precision medicine | Subathra Radhakrishnan | ![]() |
![]() |
|||
eP-453 | Survival Outcomes in Patients undergoing Liver Transplantation for Primary Sclerosing Cholangitis (PSC) and Incidental Cholangiocarcinoma | Sarah Al-Shakhshir | ![]() |
![]() |
|||
eP-455 | Impact of Everolimus versus Mycophenolate Mofetil in Combination with Reduced Tacrolimus on Oncologic Outcome after Liver Transplantation for Hepatocellular Carcinoma | Eun-Ki Min | ![]() |
![]() |
|||
eP-456 | Liver transplantation for hepatocellular carcinoma: the role of histology to predict worse disease-free and overall survival in pathological Milan Out patients in a single-center experience | Daniele Ferraro | ![]() |
![]() |
|||
eP-460 | Tyrosine Kinase Inhibitors therapy for Hepatocellular Carcinoma in patients waiting for liver transplant: is it safe? | grazia conte | ![]() |
![]() |
|||
eP-462 | Reduced Effect of Immune Checkpoint Therapy On Liver Metastases with Oral Budesonide Treatment: Implications for The Transplant Allograft? | Kymberly Watt | ![]() |
![]() |
|||
eP-463 | Domino liver transplantation for unresectable colon cancer liver metastases from a donor with heterozygous familial hyperlipidemia: A case report | YUZURU SAMBOMMATSU | ![]() |
![]() |
|||
eP-464 | Very late recurrence of hepatocellular carcinoma after living donor liver transplantation: case report | Seong-Hwan Chang | ![]() |
![]() |
|||
eP-466 | Alpha-fetoprotein response after first transarterial chemoembolization (TACE) and complete pathologic response in patients with hepatocellular cancer | Maciej Krasnod&281;bski | ![]() |
![]() |
|||
eP-467 | The impact of applying UCSF criteria to patients underwent liver transplantation for hepatocellular carcinoma in a low volume center | Doojin Kim | ![]() |
![]() |
|||
eP-468 | A case report of combination treatment (Trans arterial radio embolisation and Stereotactic beam radiotherapy) for an advanced Hepatocellular carcinoma as a bridge to liver transplantation | Deepashree Thiruchunapalli | ![]() |
![]() |
May 3-6 Rotterdam, Netherlands
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|